Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/164367
Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Objectives: To apply a systems pathology-based approach to the quantification of nuclear Active β-catenin and human leukocyte antigen class I, and assess the biomarker involvement in a cohort of prostate tumor patients. Results: The systems pathology approach applied allows a precise quantification of the marker expression in the different cell compartments as well as the determination of the areas that coexpress two markers. Our data shows that the accumulation of β-catenin in the nuclear compartment is significantly decreased in the adjacent normal areas when compared to tumor of the same patients (p < 0.001). In conclusion, the application of this novel multiple immunofluorescence assay demonstrates that the upregulation of Active β-catenin is a relatively common feature of prostate tumor development, and further supports the activation of the Wnt/β-catenin pathway in prostate cancer progression.
Subject (English)
Citation
Citation
PUIG, Pere, et al. Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer. BMC Research Notes. 2019. Vol. 12, num. 68. ISSN 1756-0500. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/164367